Press release
Leukocyte Surface Antigen CD47 Antibody Market to Reach USD 6 Billion by 2034, Growing at a 10.3% CAGR
As of 2024, the global market for Leukocyte Surface Antigen CD47 Antibody is valued at approximately $2.5 billion, driven by increased research funding, heightened awareness of immune checkpoint inhibitors, and growing prevalence of cancer and autoimmune diseases. The market is expected to expand significantly, reaching an estimated $6 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of around 10.3% during the forecast period from 2025 to 2034.Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Leukocyte Surface Antigen CD47 Antibody market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Leukocyte Surface Antigen CD47 Antibody market.
This report is also available in the following languages : Japanese (白血球表面抗原CD47抗体), Korean (백혈구 표면 항원 CD47 항체), Chinese (白细胞表面抗原CD47抗体), French (Anticorps anti-antigène de surface des leucocytes CD47), German (Leukozyten-Oberflächenantigen CD47-Antikörper), and Italian (Anticorpo antigene di superficie leucocitario CD47), etc.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/66237
Key Companies:
Johnson & Johnson , Bristol-Myers Squibb , AbbVie , Amgen , Genentech (a member of the Roche Group) , Gilead Sciences , Regeneron Pharmaceuticals , Novartis , Merck & Co. , Sanofi , Pfizer , Biogen , AstraZeneca , Takeda Pharmaceutical Company , Eli Lilly and Company
Market Segmentation
By Product Type
Monoclonal Antibodies
Polyclonal Antibodies
By Application
Cancer Treatment
Autoimmune Diseases
Research Applications
By End User
Pharmaceutical Companies
Research Laboratories
Academic Institutions
By Technology
Recombinant DNA Technology
Hybridoma Technology
By Distribution Channel
Online Sales
Direct Sales
Retail Pharmacies
Explore Full Report here: https://exactitudeconsultancy.com/reports/66237/leukocyte-surface-antigen-cd47-antibody-market
If opting for the Global version of Leukocyte Surface Antigen CD47 Antibody Market; then the below country analysis would be included:
- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=66237
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Leukocyte Surface Antigen CD47 Antibody market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Leukocyte Surface Antigen CD47 Antibody market.
Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/66237
Reasons To Buy The Leukocyte Surface Antigen CD47 Antibody Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Our team is available 24/7 to assist and support our customers through reliable research.
Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.
Other Reports:
Urine Collection Cup Market
https://exactitudeconsultancy.com/reports/65598/urine-collection-cup-market
Medical Disposable Curtain Market
https://exactitudeconsultancy.com/reports/65638/medical-disposable-curtain-market
Ginger Root Supplement Market
https://exactitudeconsultancy.com/reports/65678/ginger-root-supplement-market
Post Mortem Knives Market
https://exactitudeconsultancy.com/reports/65718/post-mortem-knives-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leukocyte Surface Antigen CD47 Antibody Market to Reach USD 6 Billion by 2034, Growing at a 10.3% CAGR here
News-ID: 4054684 • Views: …
More Releases from Exactitude Consultancy
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72069
Market Summary
The Partial Seizure Market…
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial…
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063
Market Summary
The Prediabetes Market is expanding rapidly as healthcare…
More Releases for CD47
Anti-CD47 Drugs Market to Set Phenomenal Growth From 2025 to 2034
CD47, a cell surface glycoprotein, plays a critical role in regulating immune responses and cell signaling. Often referred to as the "don't eat me" signal, CD47 interacts with its receptor, SIRPα (signal regulatory protein alpha), on macrophages and other immune cells to inhibit phagocytosis, or the process by which immune cells engulf and destroy foreign or damaged cells. Many cancer cells overexpress CD47, which helps them evade immune detection and…
CD47 Targeting Therapeutics Market Robust Expansion is expected to 2034
CD47 Targeting Therapeutics Market Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By…
CD47 Targeting Therapeutics Market Investments, Share and Revenue Analysis Repor …
CD47 Targeting Therapeutics Market Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By…
CD47 Targeting Therapeutics Market Future Trends and Scope Analysis Report
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global CD47 Targeting Therapeutics Market- by Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers and Other Diseases Indications), Type of Molecule (Biologics and Small Molecule), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to…
Future Directions in CD47 Research: Innovations and Clinical Translation
CD47, a protein that plays a critical role in immune evasion by tumor cells, has emerged as a key target in cancer research. Its ability to interact with signal regulatory protein alpha (SIRPα) on macrophages, delivering a "don't eat me" signal that prevents the phagocytosis of tumor cells, has made it a focal point for therapeutic development. As research into CD47 progresses, several innovative approaches and clinical translation efforts are…
CD47 Targeting Therapeutics Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By Type of molecule(Biologics, Small molecule) - Market Outlook and Industry Analysis 2030"
According to the latest research…
